EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $104,000 | -60.9% | 15,600 | -50.0% | 0.00% | – |
| Q2 2021 | $266,000 | +82.2% | 31,200 | +88.0% | 0.00% | – |
| Q1 2021 | $146,000 | -87.0% | 16,600 | 0.0% | 0.00% | – |
| Q4 2020 | $1,122,000 | +725.0% | 16,600 | 0.0% | 0.00% | – |
| Q3 2020 | $136,000 | -15.0% | 16,600 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $160,000 | +247.8% | 16,600 | +147.8% | 0.00% | – |
| Q1 2020 | $46,000 | -54.0% | 6,700 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $100,000 | -4.8% | 6,700 | -34.8% | 0.00% | 0.0% |
| Q3 2019 | $105,000 | – | 10,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 135,848 | $2,024,000 | 6.74% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $11,397,000 | 4.91% |
| Knoll Capital Management, LLC | 350,238 | $5,219,000 | 3.85% |
| 683 Capital Management, LLC | 1,850,000 | $27,565,000 | 3.15% |
| Soleus Capital Management, L.P. | 205,407 | $3,060,000 | 2.95% |
| Broadfin Capital, LLC | 1,236,368 | $18,422,000 | 2.47% |
| P.A.W. CAPITAL CORP | 144,000 | $2,146,000 | 2.29% |
| MANGROVE PARTNERS IM, LLC | 847,284 | $12,625,000 | 1.85% |
| Corriente Advisors, LLC | 203,898 | $3,038,000 | 1.63% |
| Trellus Management Company, LLC | 63,850 | $951,000 | 1.59% |